Skip to Content

Advances in Respiratory Medicine, Volume 92, Issue 1

2024 February - 13 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (13)

  • Review
  • Open Access
12 Citations
7,331 Views
14 Pages

The Growing Understanding of the Pituitary Implication in the Pathogenesis of Long COVID-19 Syndrome: A Narrative Review

  • Ach Taieb,
  • Ben Haj Slama Nassim,
  • Gorchane Asma,
  • Methnani Jabeur,
  • Saad Ghada and
  • Ben Abdelkrim Asma

14 February 2024

Long COVID-19, also known as post-acute sequelae of SARS-CoV-2 infection, is a condition where individuals who have recovered from the acute phase of COVID-19 continue to experience a range of symptoms for weeks or even months afterward. While it was...

  • Commentary
  • Open Access
1 Citations
4,316 Views
4 Pages

8 February 2024

Inhaled nitric oxide (iNO) is a pulmonary vasodilator that plays an important clinical ICU role. The administration of iNO is usually performed through an endotracheal tube, but spontaneously breathing patients might also benefit from iNO administrat...

  • Correction
  • Open Access
1,924 Views
3 Pages

1 February 2024

Error in Figure 3 [...]

  • Article
  • Open Access
4 Citations
3,500 Views
12 Pages

19 January 2024

Background: Ventilator-associated pneumonia (VAP) causes heavy losses in terms of finances, hospitalization, and death for elderly patients in the intensive care unit (ICU); however, the risk is difficult to evaluate due to a lack of reliable assessm...

  • Review
  • Open Access
7 Citations
3,794 Views
11 Pages

18 January 2024

Nirmatrelvir/Ritonavir is an oral treatment for mild to moderate COVID-19 cases with a high risk for a severe course of the disease. For this paper, a comprehensive literature review was performed, leading to a summary of currently available data on...

  • Article
  • Open Access
2 Citations
3,691 Views
8 Pages

17 January 2024

(1) Background: The breathing pattern is defined as the relationship between the tidal volume (VT) and breathing frequency (BF) for a given VE. The aim of this study was to evaluate whether inspiratory muscle training influenced the response of the b...

  • Article
  • Open Access
1 Citations
2,740 Views
13 Pages

Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians

  • Joanna Pepke-Zaba,
  • Luke Howard,
  • David G. Kiely,
  • Shruti Sweeney and
  • Martin Johnson

9 January 2024

Chronic thromboembolic pulmonary disease (CTEPD) is a complication of pulmonary embolism (PE). We conducted an online survey of UK PE-treating physicians to understand practices in the follow-up of PE and awareness of CTEPD. The physicians surveyed (...

  • Article
  • Open Access
4 Citations
3,463 Views
9 Pages

4 January 2024

At the population level, respiratory symptoms in children can be estimated cross-sectionally. However, such methods require additional objective support parameters, such as the measurement of fractional exhaled nitric oxide (FeNO). The aim of the pre...

  • Brief Report
  • Open Access
1 Citations
2,614 Views
9 Pages

Expression of Inflammatory Genes in Murine Lungs in a Model of Experimental Pulmonary Hypertension: Effects of an Antibody-Based Targeted Delivery of Interleukin-9

  • Judith Heiss,
  • Katja Grün,
  • Isabell Singerer,
  • Laura Tempel,
  • Mattia Matasci,
  • Christian Jung,
  • Alexander Pfeil,
  • P. Christian Schulze,
  • Dario Neri and
  • Marcus Franz

3 January 2024

Background: Pathogenesis of pulmonary hypertension (PH) is a multifactorial process driven by inflammation and pulmonary vascular remodeling. To target these two aspects of PH, we recently tested a novel treatment: Interleukin-9 (IL9) fused to F8, an...

  • Reply
  • Open Access
1,604 Views
2 Pages

22 December 2023

We are writing in response to the comment [...]

  • Article
  • Open Access
6 Citations
3,404 Views
10 Pages

The Added Value of Bronchoalveolar Lavage for Pulmonary Tuberculosis Diagnosis in High-Risk Hospitalized Patients with Negative Sputum Samples

  • Ophir Freund,
  • Yitzhac Hadad,
  • Tomer Lagziel,
  • Inbal Friedman Regev,
  • Eyal Kleinhendler,
  • Avraham Unterman,
  • Amir Bar-Shai and
  • Tal Moshe Perluk

21 December 2023

Hospitalized patients with a high suspicion of pulmonary tuberculosis (HS-PTB) are isolated until a definite diagnosis can be determined. If doubt remains after negative sputum samples, bronchoscopy with bronchoalveolar lavage (BAL) is often sought....

  • Comment
  • Open Access
3 Citations
1,809 Views
2 Pages

20 December 2023

I am writing this comment regarding the review article by Patsaki et al. titled “Benefits from Incorporating Virtual Reality in Pulmonary Rehabilitation of COPD Patients: A Systematic Review and Meta-Analysis” [...]

  • Review
  • Open Access
3,270 Views
12 Pages

Testing Alpha-1 Antitrypsin Deficiency in Black Populations

  • Pascale Lafortune,
  • Kanza Zahid,
  • Magdalena Ploszaj,
  • Emilio Awadalla,
  • Tomás P. Carroll and
  • Patrick Geraghty

19 December 2023

Alpha-1 antitrypsin (AAT) deficiency (AATD) is an under-recognized hereditary disorder and a significant cause of chronic obstructive pulmonary disease (COPD), a disease that contributes to global mortality. AAT is encoded by the SERPINA1 gene, and s...

XFacebookLinkedIn
Adv. Respir. Med. - ISSN 2543-6031